Market Overview

UPDATE: Pfizer Posts Upbeat Q3 Profit

Share:
Related PFE
S&P 500 Index Futures Trading Lower In Choppy, Volatile Session
Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global Phase 3 Trial of Targeted Therapy, IBRANCE, for Patients with Hormone Receptor–Positive Early Breast Cancer
Inflation Data Shows Continued Lack of Price Stability Progress (GuruFocus)

Pfizer (NYSE: PFE) reported a drop in its third-quarter profit.

Pfizer's quarterly profit declined to $2.59 billion, or $0.39 per share, versus a year-ago profit of $3.21 billion, or $0.43 per share, in the year-earlier period. Its adjusted earnings climbed 16% to $0.58 per share.

Its revenue fell 2% to $12.64 billion from $12.95 billion. However, analysts were projecting earnings of $0.56 per share on revenue of $12.7 billion.

Pfizer lowered its 2013 earnings view to $3.05 to $3.15 per share, versus its earlier forecast of $3.07 to $3.22 per share.

Pfizer shares closed at $30.74 yesterday.

Posted-In: profitEarnings News Guidance

 

Related Articles (PFE)

View Comments and Join the Discussion!

Get Benzinga's Newsletters